Methylxanthines: Potential Therapeutic Agents for Glioblastoma

Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Currently, treatment is ineffective and the median overall survival is 20.9 months. The poor prognosis of GBM is a consequence of several altered signaling pathways that favor the proliferation and survival of neoplastic cells...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Pérez-Pérez (Autor), Iannel Reyes-Vidal (Autor), Elda Georgina Chávez-Cortez (Autor), Julio Sotelo (Autor), Roxana Magaña-Maldonado (Autor)
Formato: Libro
Publicado: MDPI AG, 2019-09-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible